Vaccine development: Man vs MRSA

Nature

Volumn 482, Issue 7383, 2012, Pages 23-25

  McKenna, Maryn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NDV 3; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

BACTERIUM; DISEASE RESISTANCE; EPIDEMIC; IMMUNE SYSTEM; IMMUNITY; INFECTIOUS DISEASE; INFECTIVITY; INFILTRATION; MUSCLE; PHARMACEUTICAL INDUSTRY; PNEUMONIA; VACCINATION; VACCINE;

ANTIBODY PRODUCTION; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BLOODSTREAM INFECTION; COMMUNITY ACQUIRED PNEUMONIA; EMERGENCY WARD; EPIDEMIC; HAEMOPHILUS INFLUENZAE; HEALTH CARE QUALITY; HUMAN; HYPER IGE SYNDROME; IMMUNE SYSTEM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SKIN ABSCESS; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

ANIMALS; BACTERIAL VACCINES; CHILD; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; STAPHYLOCOCCAL INFECTIONS;

UNITED STATES;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84856438020     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/482023a     Document Type: Article

References (8)

1. Herold, B. C. et al. J. Am. Med. Assoc. 279, 593-598 (1998).
2. Hersh, A. L. Chambers, H. F., Maselli, J. H. & Gonzales, R. Arch. Intern. Med. 168, 1585-1591 (2008).
3. Daum, R. S. & Spellberg, B. Clin. Infect. Dis. http://dx. doi. org/10. 1093/cid/cir828 (2011).
4. Lucero, C. A. et al. Vaccine 27, 5061-5068 (2009).
5. Shinefield, H. et al. N. Engl. J. Med. 346, 491-496 (2002).
6. Kim, H. K., Cheng, A. G., Kim, H.-Y., Missiakas, D. M. & Schneewind, O. J. Exp. Med. 207, 1863-1870 (2010).
7. Holland, S. M. et al. N. Engl. J. Med. 357, 1608-1619 (2007).
8. Lin, L. et al. PLoS Pathog. 5, e1000703 (2009).